chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Familial tremors typically only cause mild hand or leg shaking. Diagnosed with tremors and associated anxiety 5 years ago.  After each vaccination shot, the tremors increased to the extent that walking and talking were difficult. Tremor-induced anxiety reduced ability to think. Severe tremors lasted about 12 hours followed by 18 hours of no energy. Normal tremors and energy returned 48 hours after injection.  Did not seek medical help.
Incorrect Moderna vaccine administered. For 2nd dose in series and CDC recommendations patient should have received Moderna dark blue cap/gray label as her 2nd dose.  Patient experienced no side effects. Family aware of error and recommendation to repeat with additional dose. Vaccine administered by LPN.  VAERS completed by CMA.
His whole heart was inflamed, he had inflammation around his heart, so he was in the hospital; His whole heart was inflamed, he had inflammation around his heart, so he was in the hospital; This is a spontaneous report from a contactable consumer (husband). A 49-year-old male patient received BNT162B2 ((PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot number: was not reported), via unspecified route of administration, as dose number unknown, single for COVID-19 immunization. Medical history and concomitant medications were not reported.  On an unspecified date, the patient's whole heart was inflamed, he had inflammation around his heart and he was hospitalized. Reporter stated that the patient was admitted in the hospital and before that he had a clean bill of record no cholesterol, no diabetes and he is not over weight. And she was assuming that the hospital was supposed to report it. Reporter stated that the only problem for calling was because she can't, bills keep coming and it was ridiculous, she cannot afford to pay all these bills that vaccine gave him this illness. The patient would like Pfizer to convince her why the rest of my family should go get a vaccine. The reporter stated that she was noticed on the news they keep saying teenagers, young teenagers, but somebody needs to tell the truth out there. Reporter was informed that the information was captured to file a safety report and if in case a follow-up is requested then it can be done by this information. The outcome of the events was unknown.   Information about lot/batch number has been requested.
Patient was given vaccine at 9 am on 9/21. At 4:30 pm that same day, he developed diffuse urticaria throughout body. Responded to Benadryl, however hives persisted. Treated Benadryl and Zyrtec. Urticaria resolved on 9/25. Patient has no known egg or other allergy. Has had flu vaccine in the past without reaction.
Tinnitus in both ears  March 22 to current date April 7, 2021  Constant.  Left ear feels full.   Doctor checked both ears - no wax or fluid. Requested a hearing test.  Have appointment to have that looked at.
extended pain; This case was reported by a consumer via interactive digital media and described the occurrence of pain in a female patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced pain. On an unknown date, the outcome of the pain was unknown.   The reporter considered the pain to be possibly related to Shingles vaccine.     Additional Information: GSK Receipt Date: 19-DEC-2022 Reporter's Comment: This case was reported by a patient via interactive digital media. The patient received first dose of Shingles vaccine and caused side effects like pain for years (extended pain). The reporter reported that the shot might be dangerous for you, too. The reporter reported that she would never take another vaccine after reading the book. The reporter reported that what had been injected into them was criminal. The reporter did not consent to follow up. Additional Supportive Information: Follow-up would not possible as no contact details were available.
Information has been received from a medical assistant referring to a 4 months old patient. Information regarding medical history and drug reactions/allergies was not reported. On 06-MAR-2015, the patient was vaccinated with a dose of ACTHIB (lot # UIO66AAA with expiration date 29-OCT-2019) when he/she was 2 months old. On 07-JUL-2016, the patient was vaccinated with a dose of MENHIBRIX (lot# ACA012A with expiration date 15-JUL-2016) when he/she was 6 months old. On 05-MAY-2015, the 4 months old patient was vaccinated with a dose of PEDVAXHIB (lot # H02059 (invalid) with expiration date 20-SEP-2016, dose and route were not reported). No adverse effects were reported. Additional information has been requested.
After first dosage, within 24 hours developed severe admoninal pain, fever, fatigue.   We thought she had the flu.  Improved.  After second dose, again adominal pain, fever, nauseau, fatigue.  Treated in ER for possible kidney infectin.   Extreme pain continued and peditrician ordered a  CT Scan performed revealing the development of two ovarian cysts.   She missed 7 weeks of school after the second dose.   Pain medication was provided while we waited for the cysts to dissolve on their own. 7/16/08-records received for DOS 9/6/07-presented to ED with C.O left lumbar pain, chills and fever. DX: UTI.
Patient looked stressed when the vaccine was administered, after few minutes he stood up and collapsed on the floor face down((syncope). He cracked his lower lip, and complained about headache 7 points from 1 to 10 scale ,Dad called 911 , EMT came in and took his vitals , patient was ok after that and walked home .called his home after 1 pm on 11/22/2020 , dad said he is ok.
It was reported that a 22 month old patient (2 of 3) received a Trihibit (combination ActHib and Tripedia) and an IPOL vaccination on 05.10.01. Reportedly sometimes after the vaccination (date not specified), the patient developed a large local reaction. From mailed correspondence received on 07/19/01, it was reported that the patient recovered from this experience. Additional patient, vaccine administrator and responsible physician information was also provided. From telephone contact on 08/07/01, it was reported that the patient developed a red, swollen, hard, warm area at the injection site in the deltoid 10-20mm in diameter. This reaction resolved. This case is closed.
Erythematous rash on her left arm and mild rash on right dorsum hand,.  Patient tool oral Benadryl and the rash resolved in  between 5-10 minutes.
Extreme pain, redness, swelling at injection site for 3 days. Fever of 100.4 F. Weak, shaky legs for 4 hours. It started about 20 hours after shot.
Received pedi Hep-A vaccine and Typhium VI vaccine on 6/21/01. Pt then traveled to abroad X 3 weeks. Appox. 2 weeks, post vax, the pt developed dizziness, nausea, decreased appetite and "shakiness". Per pt's mom, the pt was worked-up via blood and stool tests numerous times with (-) findings. Mother has questioned if these vaccines are associated with her daughter's clinical signs and symptoms (we doubt this). Mom called on 3/4/02 to review on-going problems occurring 2 weeks, post vax. Doubt correlation.
4/29/21, 12 hours following dose, 99 degrees, chills, Tylenol
shot was about noon on 27OCT95 @ about 3PM started sleeping & was diff to wake up, this cont for about 24hrs;also @ approx 8-9PM eye were going lt to rt, dec rolling back, tongue was making a repeated motion in & out, would not respond;t103
Urticaria onset about 4 hours after vaccine. RX Benadryl, than oral Allegra and Ranitadine, No oral
Fell; Dizziness; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizziness) and FALL (Fell) in a 96-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Surgery (Unspecified surgery done 5 years ago.). Concurrent medical conditions included Coronary artery disease.    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Jan-2021, the patient experienced DIZZINESS (Dizziness). On 27-Jan-2021, the patient experienced FALL (Fell). At the time of the report, DIZZINESS (Dizziness) and FALL (Fell) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment and concomitant medications were reported.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of these events, a causal relationship cannot be excluded.
Patient received MMR, VARIVAX, HAV, Flu shot on 2/15/11. In the evening the next day, he started to scratch his head. Today, he woke up with urticaria.
Patient fully vaccinated (Janssen), but not boosted, admitted to the hospital on 1/15/22 with COVID-19 and associated hypoxemia. Patient was discharged on 1/19/22.
Narrative: Patient contacted telephone triage nurse today requesting advice. Patient states he received COVID VACCINE on 2/20/2020. States within 1-2 hours, he developed dizziness, has not resolved, so he is concerned. Pt is c/o dizziness x 9 days now, since injection. Dizziness is constant, worsens with any type of movement or activity. Feels as if he is drifting when he walks, but not to one side or the other, "just a really weird, floating feeling. " No headache, slurred speech, facial droop, unilateral weakness or difficulty swallowing. Significant cardiac history. Recommended local ER, pt declines at this time, "I am going to call my family doctor first (non-hospital) and get his advice, then make a decision. " AMA disclaimer has been read, rationale was explained in depth, pt still declines at this time, "I really just wanted someone to document this reaction, I thought you should know about it. "
reported some minimal pruritis approximately 10 minutes after the Ixiaro vaccine was administered, and then she reported it "quickly went away." Per client, after about 45 minutes, she began to feel "low energy" and "shaky." She began to have some shortness of breath, burning of throat, and difficulty swallowing. Client then called her mother to pick her up and take her to urgent care for fear the symptoms would progress. Client took Benadryl 25mg and Loratidine 10 mg while at home. Client was seen and assessed at Urgent care; client said they offered to give her a steroid injection but client declined. They continued to assess her and she had no progression of symptoms. She reports this entire reaction resolved within 2-3 hours after first initial onset of symptoms.
I had a long, flu-like reaction a full week after the vaccination.  I did see a doctor at an urgent care clinic who tested me for influenza B and COVID.  I was negative for both.  Though I'm not positive this was a reaction to my booster, it seems likely, given the timing.  Doctor said that he had seen that in others.
Narrative:  Patient tested positive for COVID-19 while hospitalized despite full vaccination. Pt received 2 doses of Moderna, along with a booster on 12/13/2021. Pt was hospitalized on 1/6/2022 but was positive for COVID-19 on 1/15/2022 during hospitalization.
shingles; This case was reported by a nurse via sales rep and described the occurrence of shingles in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, less than a month after receiving Shingrix, the patient experienced shingles. On an unknown date, the outcome of the shingles was unknown.   The reporter considered the shingles to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient received the Shingrix vaccine and 2 to 3 weeks/ within weeks later developed Shingles. The reporter did not consented to follow up. This case was linked with US2021AMR234679, US2021AMR234702 and US2021235278 reported by the same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR234702:same reporter US-GLAXOSMITHKLINE-US2021AMR234679:same reporter US-GLAXOSMITHKLINE-US2021235278:same reporter - initial
Instead of the patient receiving the monovalent primary dose, the patient was given the bivalent as her first vaccine. No adverse reaction noted.
red rash over back & chest & neck started 2 days p/vax;2 days later stomachache;rash lasted 2wk;
Previous records were checked and patient notified by nurse of the patient have already received a bivalent booster before appointment. Patient stated that the establishment were they received a previous booster told them it was invalid and that they need another booster. No adverse side effects have been reported..
The nurse drawing up the vaccine only drew up a half a dose so this patient needs to come back in 8 weeks for the other half
Patient was given the Janssen vaccine and within 3 minutes the pt complained that she was lightheaded and dizzy. As I walked out of the pharmacy to see what her reaction was her muscles tensed up and she became completely rigid and stared sliding out of her chair. By appearances it looked like she was shaving a mild seizure, with a blank stare. By the time I got her down on the floor and got her coat off to see if there was an allergic reaction to the site the patient came too and asked me why she was in the floor. At that time she was clamy but knew who she was and where she was. Paramedics were called and while they were here she stated that she was dizzy and nauseous so they ended up taking her to a location hospital to be seen. While there they drew blood as a precaution.
Stomach ache, Vomiting, Vertigo, & Dizziness. I have been doing physical therapy for the vertigo.
This spontaneous report as received from a healthcare worker refers to a "college aged patient" of unknown gender. Information about concurrent medical conditions, concomitant medication and medical history was not provided. On 11-JUN-2014 the "college aged patient" was accidentally vaccinated with 0.5ml dose of PROQUAD (Merck) (injection, lot# and frequency were not provided) subcutaneously instead of ZOSTAVAX. No adverse effects reported. Additional information has been requested.
PATIENT IMMEDIATELY FELT DIZZY AND PASSED OUT A FEW SECONDS LATER. THE VACCINATOR WAS NOT ABLE TO CATCH HER FALL AND SHE FELL OUT OF THE CHAIR AND HIT HER FOREHEAD. PT WAS IN AND OUT OF CONSCIOUNESS Q5 MIN, UNRESPONSIVE TO PAINFUL STIMULI, AND MUCOUS MEMBRANES WERE BLUE FOR 30 SECONDS BEFORE JERKING AWAKE AND COLOR RETURNED TO NORMAL. SHE DENIES NECK PAIN, HEADACHE, AND SPINE INTACT. SHE REPORTED DIZZINESS, BLURRED VISION, AND RINGING IN THE EARS FOR Q15 MINUTES UNTIL RESIDED. PT PRESENTED WITH DIAPHORESIS UNTIL HER REPORTED SYMPTOMS RESIDED. VITALS, CLEAR LUNG SOUNDS, AND GLUCOMETER WERE DONE. MEDICS GAVE ORAL GLUCOSE. VITALS MONITORED UNTIL STABLE. PATIENT STAYED WITH FIRE Q1H AND SIGNED AMA WITH FIRE TO GO HOME. SCHOOL SECURITY WALKED HER HOME.
slept all day after receiving vaccines, lethargic, eyes droopy, woke up 2x only to feed for 8-10 min each time
Fever of 102, chills, body aches, headache, nausea, fatigue and pain at injection site. These symptoms lasted  about 36 hours.  Fatigue and body aches continued another 24 hours after that.
doses were given after expiration date; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (doses were given after expiration date) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 008C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 14-Oct-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (doses were given after expiration date). At the time of the report, EXPIRED PRODUCT ADMINISTERED (doses were given after expiration date) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication of the patient was not reported.  Date the vial was initially stored in the refrigerator was 17-Nov-2021. There was no temperature excursion. The reporter reported that that there was a confusion between the expiration date printed in the carton and the expiration date when the QR code was scanned.  The patient did not experience any adverse event.  No treatment information was provided by the reporter.
Flu shots were/may have been stored below freezing overnight which may decrease efficacy of vaccine.
26jun89 pt vax hepta B. pt devel. tingling from back of head to buttocks & in arms and legs. 31jul89 pt vax 2nd hepta B. pt ex tingling and cold extremities.04jan90 pt vax 3rd hepta B. 3days later pt ex tingling in extremities. .. see worm
Named person received the Moderna booster 0.25ml, today November 1st,  one month early,  from her completed 2 dose series. 2nd Moderna dose 0.5ml was given June 1, 2021 and booster dose was given Nov. 1st, 2021. Pt tolerated vaccination without any adverse effects during 15 minute observation.
This spontaneous report as received from the patient's husband via Poison and Drug Center refers to a 60 year old female patient. The patient's past medical history, past drug history, and concomitant medications were all unknown. On 19-MAY-2014 the patient was vaccinated with a dose of ZOSTAVAX, injection (dose, lot# and site not reported). On 23-MAY-2014, the patient began not feeling well, with an overall feeling of lethargy. She also developed a raised rash with welts under one of her eyes and a similar rash that run in a two-inch long line down the back of her neck. It was unknown if any relevant labs were performed. As of 24-MAY-2014, the husband reported he would be notifying his wife's physician of this reaction. The outcome of the events was unknown. It was not reported if the events were related to ZOSTAVAX. Additional information has been requested.
Pain in right lower right side of back. Using tylenol and ibuprofen  As of today still painful
headache, dizziness, hypertension,  subjective mild shortness of breath,  BP 160/100 Taken to the ER for evaluation
Elevated temp 101; hard reddened area around inject site; hives noted for 6-8cm below inject site
the freezer temperature had gone up a little bit for an hour and 15 minutes on Thursday, the vaccines were administered on Friday; the freezer temperature had gone up a little bit for an hour and 15 minutes on Thursday, the vaccines were administered on Friday; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team.  A 59-year-old male patient received BNT162b2 (BNT162B2), on 01Jul2022 as dose number unknown, single (Lot number: FK9894) at the age of 59 years for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PRODUCT ADMINISTRATION ERROR (non-serious), POOR QUALITY PRODUCT ADMINISTERED (non-serious) all with onset 01Jul2022, outcome "unknown" and all described as "the freezer temperature had gone up a little bit for an hour and 15 minutes on Thursday, the vaccines were administered on Friday".  Additional Information: reporter stated that, Other Conditions was Not Provided, Investigations was Not Provided, NDC number of Covid Vaccine was mentioned, Expiry Date of Covid Vaccine was Unknown, Other Products was Not Provided. Caller states that two patients received the affected vaccines; this is the follow up report for the first patient. Age was Unknown. Event Details was reported as, Caller states that the freezer temperature had gone up a little bit for an hour and 15 minutes on Thursday, the vaccines were administered on Friday. Suspect Product Expiry Date was Unknown. Non serious report.  No follow-up attempts are possible. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202200938535 same product, event and different patient;
This spontaneous report was received from a nurse refers to an unspecified number of patients of unknown age and gender. There was no information about the patients' concurrent conditions, concomitant therapies or medical history provided. On unknown dates, the patients were vaccinated with improperly stored doses of PROQUAD (Merck) lot # reported as L047307, expiration date 23-MAY-2017 (dose and route of administration were not reported). The nurse indicated that those vaccines were subjected to multiple defrost cycles (no more than 4 cycles per day lasting 30 minutes for each cycle and not exceeding temperatures over -14.5 degrees Celsius). No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Janssen- lot #1805018] use for COVID-19 under Emergency Use Authorization (EUA): Since the time of vaccination on 3/16/2021 patient reports dramatic increase in tinnitus above her baseline casusing issues with sleep and hearing people talking. Patient has had hypertension contolled with diet and exercise, however, since vaccination she is having erratic readings as high as 110/185 and now with diastolic readings reading high. Blood sugars have also been erratically high since vaccination. Morning sugars in past had been 110-130 and are now 140-190. Both HTN and NIDDM had been well controlled prior to vaccination.    Diastolic elevations continue Erratic blood sugars continue to be elevated Tinnitus continues to be problematic for patient
Had Vaccine on 01/22/2021, also had a possible exposure on this same date so not sure if r/t that or vaccine. Started feeling bad on 1/24/21 and tested positive for COVID on 01/25/2021. Was sick with severe flu-like symptoms for a little over 2 weeks. Finally started feeling well enough on 2/10/21 to return to work on 2/11/21.
Profound nausea, splitting headache (8 on a scale of 1-10), vertigo and swelling and soreness at injection site.
The patient's mother reports that the day after his vaccination the child developed a rash, and periorbital swelling. She also reported that the child stopped saying the few words he was already saying. The child wasn't brought to medical attention the day when these events occurred. The rash and periorbital swelling resolved. The child began to babble "mamma" a few days ago. There's family history of speech delay.
expired vaccine administered; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (expired vaccine administered) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 04-Oct-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (expired vaccine administered). On 04-Oct-2021, EXPIRED PRODUCT ADMINISTERED (expired vaccine administered) had resolved.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications were not reported.  Reporter stated there was a box of moderna vials and marked it with the date 10.3. reporter stated that was meant to be the 30-day expiration date, but a medical assistant was not aware because it was not marked with expires on 10.3. The vaccine was administered to one male patient. Patient waited about 20 minutes after he was administered the vaccine, no adverse reactions noted. Vial was moved from freezer to refrigerator on 3-sep-2021.  No treatment information was provided.  It was analyzed, regarding the dose administered on 04-oct-2021: Moderna cannot guarantee patient received full protection against the Covid-19 virus.     Most recent FOLLOW-UP information incorporated above includes: On 07-Oct-2021: Follow Up received: Additional information added in inarrative.